Document is current
Any future updates will be listed below
-
Authors
Lotter, Leon D. https://orcid.org/0000-0002-2337-6073
Saberi, Amin https://orcid.org/0000-0002-7043-0722
Hansen, Justine Y. https://orcid.org/0000-0003-3142-7480
Misic, Bratislav https://orcid.org/0000-0003-0307-2862
Paquola, Casey
Barker, Gareth J. https://orcid.org/0000-0002-5214-7421
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta https://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Garavan, Hugh https://orcid.org/0000-0002-8939-1014
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Paillère, Marie-Laure
Artiges, Eric https://orcid.org/0000-0003-4461-7646
Papadopoulos Orfanos, Dimitri https://orcid.org/0000-0002-1242-8990
Paus, Tomáš https://orcid.org/0000-0003-1495-9338
Poustka, Luise
Hohmann, Sarah https://orcid.org/0000-0002-5175-6698
Fröhner, Juliane H. https://orcid.org/0000-0002-8493-6396
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi https://orcid.org/0000-0002-4600-7158
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
,
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Eickhoff, Simon B.
Dukart, Juergen https://orcid.org/0000-0003-0492-5644
- License Information
-
More Information
Article History
Received: 9 November 2023
Accepted: 29 August 2024
First Online: 12 September 2024
Competing interests
: Dr. Banaschewski served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, and Shire. He received conference support or speaker’s fees from Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire and Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. The present work is unrelated to the above grants and relationships. Dr. Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. Dr. Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fees from Shire. She received royalties from Hogrefe, Kohlhammer, and Schattauer. The present work is unrelated to the above grants and relationships. All other authors report no biomedical financial interest or other potential conflicts of interest.
